Global Hormonal Contraceptive Market Analysis & Industry Forecast 2017-2023, With an Expected CAGR of Almost 2% - ResearchAndMarkets.com

DUBLIN--()--The "Hormonal Contraceptive Market by Product, Hormone, Age Group, and End User - Global Opportunity Analysis and Industry Forecast, 2017-2023" report has been added to ResearchAndMarkets.com's offering.

The global hormonal contraceptive market was valued at $13,924 million in 2016, and is estimated to reach $16,018 million by 2023, registering a CAGR of 1.9% from 2017 to 2023.

Hormonal contraception is a birth control method, which acts on the endocrine system, and is composed of steroid hormones. Higher concentration of naturally forming hormones such as estrogen and progesterone are used to either prevent ovulation or make unfavorable condition to develop pregnancy.

Increase in adoption of hormonal contraceptives products or birth control methods in the developing countries and incidence of polycystic ovary syndrome (PCOS) are the major driving factors for the growth of the global hormonal contraceptive market. Moreover, rise in population attaining higher education and rise in need to control the ever-growing population in developing regions such as China and India have adopted measures to prevent unwanted pregnancy, which are expected to fuel the market growth. However, availability of alternate contraceptive methods and health risks associated with the use of contraceptives hamper the market growth.

The global hormonal contraceptive market is segmented on the basis of product, hormone, age group, end user, and geography. Based on product, the market is classified into oral contraceptive pills, injectable birth control, emergency contraceptive pills, vaginal rings, and transdermal patches. Depending on hormone, it is bifurcated into progestin-only contraceptive and combined hormonal contraceptive. By age group, it is categorized into 15-24 years, 25-34 years, 35-44 years, and above 44 years. By end user, it is classified into hospitals, household, and clinics. Geographically, it is analyzed across four regions, namely, North America, Europe, Asia-Pacific, and LAMEA.

Companies Mentioned:

  • The Female Health Company
  • Teva Pharmaceutical Industries Limited
  • Bayer AG
  • Pfizer, Inc.
  • Mylan N.V.
  • Johnson & Johnson
  • Ansell Ltd.
  • Mayer Laboratories
  • Merck & Co., Inc.
  • Church & Dwight, Co., Inc.

Key Topics Covered:

1: Introduction

2: Executive Summary

3: Market Overview

4: Hormonal Contraceptive Market By Product

5: Hormonal Contraceptive Market By Hormone

6: Hormonal Contraceptive Market By Age Group

7: Hormonal Contraceptive Market By End Users

8: Hormonal Contraceptive Market By Geography

9: Company Profiles

For more information about this report visit https://www.researchandmarkets.com/research/npk9hb/global_hormonal?w=4

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health

Contacts

ResearchAndMarkets.com
Laura Wood, Senior Manager
press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900
Related Topics: Women's Health